GEMFIBROZIL
- Product NDC
- 72162-2119
- 11-digit product format
- 721622119
- Labeler code
- 72162
- Product ID
- 72162-2119_cfb9ebc5-4268-4d5b-a5db-1078913644bf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gemfibrozil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA214603
- Marketing category
- ANDA
- Marketing start
- 2021-01-20
- Substance
- GEMFIBROZIL
- Active strength
- 600 mg/1
- Pharmacologic classes
- PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214603-001 | GEMFIBROZIL | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214603-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 5aa47cf7b7d7… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214603-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 2021-01-13 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A214603-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A214603-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214603-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A214603-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214603-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214603-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214603-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214603-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214603-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214603-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A214603-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214603-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214603-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214603-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A214603-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A214603-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A214603-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A214603-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A214603-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A214603-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A214603-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A214603-001 | AB | 1 | 5aa47cf7b7d7… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A214603-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A214603-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A214603-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A214603-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A214603-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A214603-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A214603-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A214603-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A214603-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A214603-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A214603-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A214603-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A214603-001 | AB | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214603-001 | AB | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GEMFIBROZIL
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GEMFIBROZIL | 600 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| Q8X02027X3 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310459 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 54c65a5d-2ff9-493a-90d9-2cff48d1a072 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 931dfe50-414f-e1ab-9c88-b15c4ba31929 | Product name | 5 | 20210615 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2119-6 | GEMFIBROZIL | 60 in 1 BOTTLE | TABLET | 60 | 100 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2119-6 | EA - Each | 72162-2119 | 7b9b1afd-3f54-48bf-8f3c-8c6ac4df9bc3 | 1 | 2023-10-16 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-2119 | GEMFIBROZIL TABLET [BRYANT RANCH PREPACK] | 100 | Current NDC, 1 package rows | 20230916_54c65a5d-2ff9-493a-90d9-2cff48d1a072.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GEMFIBROZIL | GEMFIBROZIL | Preferred Pharmaceuticals, Inc. | 2f5738ac-1c9c-4f3a-8c7d-6039d768831e | 2026-05-04 | Warnings, Adverse reactions | 214603 ANDA214603 |
| GEMFIBROZIL | GEMFIBROZIL | NuCare Pharmaceuticals,Inc. | bfddc3bd-c2dc-449e-e053-2a95a90a8adc | 2026-03-05 | Warnings, Adverse reactions | 214603 ANDA214603 |
| GEMFIBROZIL | GEMFIBROZIL | A-S Medication Solutions | 1967afce-ce55-4b10-bd8c-e4e94130de87 | 2025-12-18 | Warnings, Adverse reactions | 214603 ANDA214603 |
| GEMFIBROZIL | GEMFIBROZIL | A-S Medication Solutions | 929d6a30-ab06-4b43-9147-ab2cc613b41f | 2025-12-06 | Warnings, Adverse reactions | 214603 ANDA214603 |
| GEMFIBROZIL | GEMFIBROZIL | REMEDYREPACK INC. | 42e40524-57e9-4fee-993f-be0fda14936b | 2025-10-02 | Warnings, Adverse reactions | 214603 ANDA214603 |
| GEMFIBROZIL | GEMFIBROZIL | Proficient Rx LP | e52c9c88-8197-48b4-88cb-1b4b22ceaf16 | 2025-04-01 | Warnings, Adverse reactions | 214603 ANDA214603 |
| GEMFIBROZIL | GEMFIBROZIL | Bryant Ranch Prepack | fe98f68c-7182-4a88-93a5-cbdbb37fb8c2 | 2024-08-26 | Warnings, Adverse reactions | 214603 ANDA214603 |
| GEMFIBROZIL | GEMFIBROZIL | Bryant Ranch Prepack | 54c65a5d-2ff9-493a-90d9-2cff48d1a072 | 2023-09-15 | Warnings, Adverse reactions | 214603 ANDA214603 72162-2119 |
| GEMFIBROZIL | GEMFIBROZIL | Aphena Pharma Solutions - Tennessee, LLC | 7379a1c1-d34f-4eb8-acb8-c5cbaea0f017 | 2021-11-01 | Warnings, Adverse reactions | 214603 ANDA214603 |
| GEMFIBROZIL | GEMFIBROZIL | Camber Pharmaceuticals, Inc. | f6a2362a-21e1-442d-9f5d-9e600b5a2ea8 | 2021-08-26 | Warnings, Adverse reactions | 214603 ANDA214603 |
| GEMFIBROZIL | GEMFIBROZIL | XLCare Pharmaceuticals, Inc. | 58c1f50b-9f84-42fe-b7dd-6eece286e28b | 2021-08-26 | Warnings, Adverse reactions | 214603 ANDA214603 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310459 | gemfibrozil 600 MG Oral Tablet | PSN | 54c65a5d-2ff9-493a-90d9-2cff48d1a072 | 100 |
| 310459 | gemfibrozil 600 MG Oral Tablet | SCD | 54c65a5d-2ff9-493a-90d9-2cff48d1a072 | 100 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72162-2119-6 | 72162211906 | 60 TABLET in 1 BOTTLE (72162-2119-6) | 60 tablet | 2023-09-15 | No | No | Current |